2,703
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Chitosan nanoparticles induced the antitumor effect in hepatocellular carcinoma cells by regulating ROS-mediated mitochondrial damage and endoplasmic reticulum stress

, , , &
Pages 747-756 | Received 10 Oct 2018, Accepted 16 Jan 2019, Published online: 15 Mar 2019

References

  • Jiang S, Franco YL, Zhou Y, et al. Nanotechnology in retinal drug delivery. Int J Ophthalmol. 2018;11:1038–1044.
  • Hartshorn CM, Bradbury MS, Lanza GM, et al. Nanotechnology strategies to advance outcomes in clinical cancer care. ACS Nano. 2018;12:24–43.
  • Sun T, Zhang YS, Pang B, et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl. 2014;53:12320–12364.
  • Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005;5:161–171.
  • Farokhzad OC, Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev. 2006;58:1456–1459.
  • Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science. 2004;303:1818–1822.
  • Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751–760.
  • Mohapatra S, Mallick SK, Maiti TK, et al. Synthesis of highly stable folic acid conjugated magnetite nanoparticles for targeting cancer cells. Nanotechnology. 2007;18:385102.
  • Service RF. American Chemical Society meeting. Nanomaterials show signs of toxicity. Science. 2003;300:243
  • Oberdörster G. Lung particle overload: implications for occupational exposures to particles. Regul Toxicol Pharmacol. 1995;21:123–135.
  • Kim JS, Yoon TJ, Yu KN, et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci. 2006;89:338–347.
  • Li N, Sioutas C, Cho A, et al. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect. 2003;111:455–460.
  • Sahu D, Kannan GM, Vijayaraghavan R, et al. Nanosized zinc oxide induces toxicity in human lung cells. ISRN Toxicol. 2013;2013:316075.
  • Calcabrini A, Meschini S, Marra M, et al. Fine environmental particulate engenders alterations in human lung epithelial A549 cells. Environ Res. 2004;95:82–91.
  • Nel A, Xia T, Mädler L, et al. Toxic potential of materials at the nanolevel. Science. 2006;311:622–627.
  • Zhu Y, Zhao Q, Li Y, et al. The interaction and toxicity of multi-walled carbon nanotubes with Stylonychia mytilus. J Nanosci Nanotechnol. 2006;6:1357–1364.
  • Huerta-García E, Pérez-Arizti JA, Márquez-Ramírez SG, et al. Titanium dioxide nanoparticles induce strong oxidative stress and mitochondrial damage in glial cells. Free Radic Biol Med. 2014;73:84–94.
  • Park EJ, Choi DH, Kim Y, et al. Magnetic iron oxide nanoparticles induce autophagy preceding apoptosis through mitochondrial damage and ER stress in RAW264.7 cells. Toxicol in Vitro. 2014;28:1402–1412.
  • Subhapradha N, Shanmugam V, Shanmugam A. Chitosan nanoparticles from marine squid protect liver cells against N-diethylnitrosoamine-induced hepatocellular carcinoma. Carbohydr Polym. 2017;171:18–26.
  • Khan MA, Zafaryab M, Mehdi SH, et al. Characterization and carboplatin loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies. Int J Biol Macromol. 2017;97:115–122.
  • Zhang H, Wu F, Li Y, et al. Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone. Beilstein J Nanotechnol. 2016;7:1861–1870.
  • Kang BS, Choi JS, Lee SE, et al. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles. Carbohydr Polym. 2017;159:39–47.
  • Su C, Li H, Shi Y, et al. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid. Int J Pharm. 2014;474:202–211.
  • Shi Y, Su C, Cui W, et al. Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells. J Nanobiotechnology. 2014;12:43.
  • Janes KA, Fresneau MP, Marazuela A, et al. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release. 2001;73:255–267.
  • De Campos AM, Sánchez A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm. 2001;224:159–168.